CY1117688T1 - Ενωσεις τετραϋδροπυρρολοθειαζινης - Google Patents

Ενωσεις τετραϋδροπυρρολοθειαζινης

Info

Publication number
CY1117688T1
CY1117688T1 CY20161100566T CY161100566T CY1117688T1 CY 1117688 T1 CY1117688 T1 CY 1117688T1 CY 20161100566 T CY20161100566 T CY 20161100566T CY 161100566 T CY161100566 T CY 161100566T CY 1117688 T1 CY1117688 T1 CY 1117688T1
Authority
CY
Cyprus
Prior art keywords
compounds
tetrahydropyrrolothiazine
tetrahydropyrrolothiazine compounds
ch2oh
och3
Prior art date
Application number
CY20161100566T
Other languages
English (en)
Inventor
James Peter Beck
Steven James Green
Jose Eduardo Lopez
Brian Michael Mathes
Dustin James Mergott
Warren Jaye Porter
Zoran Rankovic
Yuan Shi
Brian Morgan Watson
Jr Leonard Larry Winneroski
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of CY1117688T1 publication Critical patent/CY1117688T1/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Η παρούσα εφεύρεση παρέχει ενώσεις του Τύπου I: όπου Α επιλέγεται από την ομάδα που αποτελείται από· (a), (b), (c) και (d), R1 είναι Η ή F· R2 είναι Η, -CH2OH, C1-C3 αλκύλ, (e) ή (f), R3 είναι Η, F, ή CN· R4 είναι Η, F· ή CN· και R5 είναι Η, -CH3, ή -OCH3· ή φαρμακευτικώς αποδεκτό άλας αυτών.
CY20161100566T 2012-04-03 2016-06-24 Ενωσεις τετραϋδροπυρρολοθειαζινης CY1117688T1 (el)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201261619460P 2012-04-03 2012-04-03
US201261700960P 2012-09-14 2012-09-14
US201361758798P 2013-01-31 2013-01-31
PCT/US2013/033959 WO2013151832A1 (en) 2012-04-03 2013-03-27 Tetrahydropyrrolothiazine compounds

Publications (1)

Publication Number Publication Date
CY1117688T1 true CY1117688T1 (el) 2017-05-17

Family

ID=48083661

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20161100566T CY1117688T1 (el) 2012-04-03 2016-06-24 Ενωσεις τετραϋδροπυρρολοθειαζινης

Country Status (19)

Country Link
US (3) US8629270B2 (el)
EP (1) EP2836495B1 (el)
JP (1) JP6067099B2 (el)
CN (1) CN104185635B (el)
AR (1) AR090474A1 (el)
CA (1) CA2866201C (el)
CY (1) CY1117688T1 (el)
DK (1) DK2836495T3 (el)
ES (1) ES2584827T3 (el)
HR (1) HRP20160674T1 (el)
HU (1) HUE030097T2 (el)
JO (1) JO3143B1 (el)
ME (1) ME02404B (el)
PL (1) PL2836495T3 (el)
PT (1) PT2836495T (el)
RS (1) RS54899B1 (el)
SI (1) SI2836495T1 (el)
TW (1) TWI572610B (el)
WO (1) WO2013151832A1 (el)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2548774T3 (es) 2008-01-18 2015-10-20 Eisai R&D Management Co., Ltd. Derivado de aminodihidrotiazina condensado
EP2912041B1 (en) 2012-10-26 2016-12-14 Eli Lilly and Company Tetrahydropyrrolothiazine derivatives as bace inhibitors
TWI593692B (zh) * 2013-03-12 2017-08-01 美國禮來大藥廠 四氫吡咯并噻嗪化合物
TWI684452B (zh) * 2014-03-14 2020-02-11 美國禮來大藥廠 胺基噻嗪化合物
TWI570127B (zh) * 2014-09-15 2017-02-11 美國禮來大藥廠 結晶型N-[3-[(4aR,7aS)-2-胺基-6-(5-氟嘧啶-2-基)-4,4a,5,7-四氫吡咯并[3,4-d][1,3]噻嗪-7a-基]-4-氟-苯基]-5-甲氧基-吡嗪-2-甲醯胺、其用途及醫藥組合物
US20210355138A1 (en) * 2016-08-11 2021-11-18 Eli Lilly And Company Aminothiazinies and their use as bace1 inhibitors
TWI726329B (zh) 2018-06-22 2021-05-01 美商美國禮來大藥廠 2,3-二氫呋喃并[2,3-b]吡啶化合物
CN111184725B (zh) * 2020-02-27 2020-12-01 慈溪市人民医院医疗健康集团(慈溪市人民医院) 一种防治脑梗塞的药物制剂及其制备方法
CN111675659B (zh) * 2020-06-16 2022-03-11 阿里生物新材料(常州)有限公司 一种(5-氟嘧啶-4-基)甲醇的合成方法
CN112263583B (zh) * 2020-11-23 2021-10-22 诸城市精神卫生中心 一种治疗帕金森疾病的药物及其制备方法
CN113666878A (zh) * 2021-08-27 2021-11-19 宁夏常晟药业有限公司 一种5-溴-2-氯嘧啶-4-羧酸甲酯的合成方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI332005B (en) 2005-06-14 2010-10-21 Schering Corp Aspartyl protease inhibitors
JP5383483B2 (ja) * 2007-04-24 2014-01-08 塩野義製薬株式会社 アルツハイマー症治療用医薬組成物
ES2548774T3 (es) 2008-01-18 2015-10-20 Eisai R&D Management Co., Ltd. Derivado de aminodihidrotiazina condensado
AU2009239536C1 (en) 2008-04-22 2012-12-13 Merck Sharp & Dohme Corp. Phenyl-substituted 2-imino-3-methyl pyrrolo pyrimidinone compounds as BACE-1 inhibitors, compositions, and their use
TW201016708A (en) 2008-09-30 2010-05-01 Eisai R&D Man Co Ltd Novel fused aminodihydrothiazine derivative
AR077277A1 (es) 2009-07-09 2011-08-17 Lilly Co Eli Compuestos de biciclo (1,3)tiazin-2-amina formulacion farmaceutica que lo comprende y su uso para la manufactura de un medicamento util para el tratamiento de la enfermedad de alzheimer
GB0912778D0 (en) * 2009-07-22 2009-08-26 Eisai London Res Lab Ltd Fused aminodihydro-oxazine derivatives
US7964594B1 (en) * 2009-12-10 2011-06-21 Hoffmann-La Roche Inc. Amino oxazine derivatives
EP2511269A4 (en) 2009-12-11 2013-04-24 Shionogi & Co FUSED HETEROCYCLIC COMPOUND HAVING AN AMINO GROUP
WO2012162334A1 (en) 2011-05-24 2012-11-29 Bristol-Myers Squibb Company Compounds for the reduction of beta-amyloid production
WO2013030713A1 (en) 2011-08-31 2013-03-07 Pfizer Inc. Hexahydropyrano [3,4-d][1,3] thiazin-2-amine compounds

Also Published As

Publication number Publication date
CA2866201A1 (en) 2013-10-10
CN104185635B (zh) 2016-03-09
HUE030097T2 (en) 2017-04-28
RS54899B1 (sr) 2016-10-31
JP2015512445A (ja) 2015-04-27
ES2584827T3 (es) 2016-09-29
EP2836495B1 (en) 2016-05-18
SI2836495T1 (sl) 2016-06-30
JP6067099B2 (ja) 2017-01-25
EP2836495A1 (en) 2015-02-18
AR090474A1 (es) 2014-11-12
JO3143B1 (ar) 2017-09-20
US8772282B2 (en) 2014-07-08
WO2013151832A1 (en) 2013-10-10
TW201400491A (zh) 2014-01-01
PT2836495T (pt) 2016-07-18
US20140256933A1 (en) 2014-09-11
US20130261111A1 (en) 2013-10-03
CN104185635A (zh) 2014-12-03
DK2836495T3 (en) 2016-08-15
ME02404B (me) 2016-09-20
CA2866201C (en) 2016-09-20
US20140094454A1 (en) 2014-04-03
US8629270B2 (en) 2014-01-14
US8889856B2 (en) 2014-11-18
PL2836495T3 (pl) 2016-11-30
TWI572610B (zh) 2017-03-01
HRP20160674T1 (hr) 2016-07-15

Similar Documents

Publication Publication Date Title
CY1117688T1 (el) Ενωσεις τετραϋδροπυρρολοθειαζινης
CY1120705T1 (el) Καινοφανεις αναστολεις αποακετυλασων ιστονων
CY1120188T1 (el) ΠΑΡΑΓΩΓΑ ΝΑΦΘΥΡΙΔΙΝΗΣ ΧΡΗΣΙΜΑ ΩΣ ΑΝΤΑΓΩΝΙΣΤΕΣ ΙΝΤΕΓΚΡΙΝΗΣ αvβ6
CY1121677T1 (el) Ενωσεις διμεθυλοβενζοϊκου οξεος
CY1124537T1 (el) Παραγωγο πυριδονης που εχει τετραϋδροπυρανυλ μεθυλ ομαδα
CY1118623T1 (el) Ενωσεις τετραϋδροπυρρολοθειαζινων ως αναστολεις της bace
CY1119585T1 (el) Ενωσεις τετραϋδροπυρρολοθειαζινης
CY1121804T1 (el) Καινοτομες ενωσεις πυριμιδινης και πυριδινης και η χρηση τους
PH12016501007A1 (en) Substituted benzamides and methods of use thereof
CR20150085A (es) Nuevas 6-aminoacido-heteroarildihidropirmidindas para el tratamiento y profilaxis de la infección del virus de la hepatitis b
EA201401054A1 (ru) N-циклиламиды в качестве нематоцидов
EA201591634A1 (ru) Дигидропиридопиримидиновые соединения
EA201590534A1 (ru) Новые бициклические производные
RS54730B1 (sr) Inhibitori beta sekretaze
PE20160523A1 (es) Derivados de arilo o heteroarilo como inhibidores de moleculas pequenas de fibrosis
MX2016011992A (es) Derivados de piperidina-diona.
EA201691272A1 (ru) Тетрагидропиридопиразины в качестве модуляторов gpr6
MY169043A (en) New dihydroquinoline-2-one derivatives
CY1119425T1 (el) Ενωσεις φαινοξυαιθυλο πιπεριδινης
CR20140306A (es) Fluormetil -5,6-dihidro-4h-[1,3] oxazinas
EA201101060A1 (ru) Новые гербициды
EA201591486A1 (ru) Соединения имидазопиридина
EA201101148A1 (ru) Новые гербициды
MY169267A (en) New aryl-quinoline derivatives
CY1119583T1 (el) Φαινοξυαιθυλο παραγωγα κυκλικης αμινης και η δραστικοτητα τους ως τροποποιητες του ερ4 υποδοχεα